News & Videos - X-FAB - English

Regulatory News: X-FAB (BOURSE:XFAB): Highlights Q4 2024: Revenue was USD 188.8 million, down 21% year-on-year (YoY) and down 9% quarter-on-quarter (QoQ) Excluding the impact from revenue recognized over time (IFRS 15), revenue was USD 196.8 million, within the guided range of USD 195-205 million EBITDA at USD 39.8 million, down 33% YoY and down 21% QoQ EBITDA margin of 21.1%; excluding IFRS 15 impact, EBITDA margin was 22.8%, compared to the guidance of 22-25% EBIT was USD 10.6 million, down...

Regulatory News: X-FAB (BOURSE:XFAB): On the occasion of X-FAB Silicon Foundries’ virtual Capital Markets Update to be held today at 4 p.m. CET, X‑FAB reaffirms its ambition to grow to annual revenues of USD 1.5 billion and expects this target to be achieved by 2030. X-FAB subsequently announces the following update to its financial targets: Target 2026 Outlook 2030 Revenue USD ~1.05 bn USD ~1.5 bn EBITDA margin ~30% ~35% During the online conference, X-FAB will provide an update on the...

Regulatory News: X-FAB Silicon Foundries SE (BOURSE:XFAB) Highlights Q2 2023: › Revenue was USD 227.1 million, up 20% year-on-year (YoY) and 9% quarter-on-quarter (QoQ); including USD 8.3 million of revenues recognized over time due to long-term customer contracts in accordance with IFRS 15 › Excluding this positive effect, revenues* would have been USD 218.9 million, within the guided USD 205-220 million › Strong growth in X-FAB’s key end markets – automotive, industrial, and medical...

Regulatory News: On the occasion of X-FAB Silicon Foundries SE’s (X-FAB Group) (BOURSE:XFAB) Investor Day to be held today, 7th June 2023 in Paris, France, X-FAB Silicon Foundries SE announces its new outlook of USD 1.5 billion revenue and EBITDA margin of 30-35% as targets to achieve by 2026. About X-FAB X-FAB is the leading analog/mixed-signal and MEMS foundry group manufacturing silicon wafers for automotive, industrial, consumer, medical, and other applications. Its customers worldwide...

Regulatory News: X-FAB Silicon Foundries SE (BOURSE:XFAB): Highlights Q1 2023: › Revenue was USD 208.1 million, within the guided USD 205-220 million, up 16% year-on-year (YoY) and up 13% quarter-on-quarter (QoQ) › Record revenues with strong 28% year-on-year growth across X-FAB’s key end markets automotive, industrial, and medical › EBITDA at USD 58.0 million, up 41% YoY › EBITDA margin of 27.9%, above the guided 22-26% › EBIT was USD 37.4 million, up 68% YoY, with an EBIT margin of...

Regulatory News: X-FAB Silicon Foundries SE (BOURSE:XFAB) Highlights Q4 2022: › Revenue was USD 183.6 million, within the guided USD 180-190 million, up 7% year-on-year (YoY) and down 2% quarter-on-quarter (QoQ) › All-time high automotive revenue at USD 104.4 million, up 25% YoY › Consistently strong demand with bookings at USD 191.5 million and a backlog at USD 480.5 million › EBITDA at USD 42.2 million, up 24% YoY › EBITDA margin of 23.0%, within the guided 20-24% › EBIT was USD...

Regulatory News: Highlights Q3 2022: › Revenue was USD 188.3 million, within the guided USD 182-192 million, up 11% year-on-year (YoY) and flat quarter-on-quarter (QoQ) › Consistently strong demand across X-FAB’s key end markets, with bookings totaling USD 217.0 million, up 9% YoY, while industrial and silicon carbide revenues were at record levels › EBITDA at USD 9.2 million with a 4.9% margin due to the USD 36.8 million one-off impact from arbitration proceedings; excluding this...

Regulatory News: Publication of inside information pursuant to Article 17 of the Market Abuse Regulation As reported in the second quarter results release dated July 28, 2022 and in the half-year report published on September 6, 2022, X-FAB recorded a provision in its condensed consolidated financial statements totaling USD 13.8 million in the second quarter of 2022 for expenses relating to interest payments to be paid to a supplier and for associated legal fees. The provision was required as a...

Regulatory News: Highlights Q2 2022: › Revenue was USD 188.8 million, at the upper end of the guided USD 180-190 million, up 17% year-on-year (YoY) and up 6% quarter-on-quarter (QoQ) › Strong growth and continuously strong demand across all key end markets › EBITDA margin of 22.5%, within the 20-24% guidance › EBITDA was USD 42.5 million, down 2% YoY and up 3% QoQ › EBIT was USD 24.0 million, down 2% YoY and up 8% QoQ Outlook: › Q3 2022 revenue is expected to be in the range of USD...

Regulatory News: Highlights Q1 2022: › Revenue was USD 178.7 million, within the guidance of USD 175-185 million, up 15% year-on-year (YoY) and up 4% quarter-on-quarter (QoQ) › Continued strong demand with bookings at USD 239.3 million resulting in a book-to-bill ratio of 1.34 › EBITDA margin of 23.0%, at the upper end of the 19-23% guidance › EBITDA was USD 41.0 million, up 15% YoY and up 21% QoQ › EBIT was USD 22.2 million, up 31% YoY and up 57% QoQ Outlook: › Q2 2022 revenue is...

Regulatory News: Highlights Q4 2021: › Revenue was USD 172.3 million, within the guidance of USD 170-180 million, up 27% year-on-year (YoY) and up 2% quarter-on-quarter (QoQ) › Record quarterly bookings at USD 249.5 million, up 31% YoY and 25% QoQ › EBITDA margin of 19.7%, within the 19-23% guidance › EBITDA was USD 33.9 million, up 51% YoY and down 16% QoQ › EBIT was USD 14.2 million, up USD 10.6 million YoY and down USD 7.2 million QoQ Highlights 2021: › Revenue was USD 657.8...

Regulatory News: (Paris:XFAB) Highlights Q3 2021: › Revenue was USD 169.1 million, at the upper end of the guided USD 162-170 million, up 76% year-on-year (YoY) and up 5% quarter-on-quarter (QoQ) › New quarterly records achieved for industrial revenues with USD 38.3 million, medical revenues with USD 14.3 million and prototyping revenues with USD 25.6 million › Bookings came in at USD 199.0 million, remaining at a high level, up 78% YoY and down 5% QoQ › EBITDA margin of 23.9%, clearly...

Regulatory News: (Paris:XFAB) Highlights Q2 2021: › Revenue was USD 161.0 million, exceeding the guidance of USD 154-160 million, up 36% year-on-year (YoY) and up 4% quarter-on-quarter (QoQ) › Bookings came in at USD 209.1 million remaining at a high level, up 110% YoY and flat QoQ › EBITDA margin of 26.9%, clearly above the 17-21% guidance › EBITDA was USD 43.3 million, up 173% YoY and up 22% QoQ › EBIT was USD 24.6 million, up USD 27.4 million YoY and up USD 7.6 million QoQ Outlook:...

Regulatory News: X-FAB (Paris:XFAB) Highlights Q1 2021: › Revenue was USD 155.4 million, clearly exceeding the initial guidance of USD 145-152 million, up 22% year-on-year (YoY) and up 14% quarter-on-quarter (QoQ) › Record quarterly bookings at USD 210.9 million, up 42% YoY and up 11% QoQ › EBITDA margin of 22.9%, clearly above the 16-20% guidance › EBITDA was USD 35.6 million, up 105% YoY and up 58% QoQ › EBIT was USD 17.0 million, up USD 18.5 million YoY and up USD 13.4 million QoQ...

Regulatory News: X-FAB (Paris:XFAB) Highlights Q4 2020: › Revenue was USD 135.9 million, clearly exceeding the initial guidance of USD 120-127 million, up 20% year-on-year (YoY) and up 41% quarter-on-quarter (QoQ) › Record quarterly bookings at USD 190.7 million, up 49% YoY and up 71% QoQ › Record medical revenue at USD 12.0 million, up 90% YoY and up 57% QoQ › EBITDA margin of 16.6%, clearly above the 10-14% guidance › EBITDA was USD 22.5 million, up USD 25.1 million YoY and up USD...

Regulatory News: X-FAB (Paris:XFAB) Q4 2020 revenues substantially exceeding the guidance range X-FAB closed the fourth quarter of 2020 with revenues amounting to approximately USD 136 million (preliminary figure*), clearly exceeding the guided range of USD 120-127 million. Compared to the same quarter last year, revenues increased by 20%, while quarter-on-quarter they rose 42%. In the course of the quarter, more and more customers requested their delivery dates to be pulled forward, resulting...

Regulatory News: X-FAB (Paris:XFAB) Highlights Q3 2020: - Revenue was USD 96.1 million, within the guidance of USD 91-97 million, down 26% year-on-year (YoY) and down 19% quarter-on-quarter (QoQ) - Bookings were USD 111.6 million, down 8% YoY and up 12% QoQ, recording a substantial increase in September - EBITDA margin of 4.9% above the 0-4% guidance - EBITDA was USD 4.7 million, down USD 7.9 million YoY and down USD 11.1 million QoQ - EBIT was USD -13.9 million, down USD 7.8 million YoY and...

Regulatory News: X-FAB (Paris:XFAB) Highlights Q2 2020: - Revenue was USD 118.8 million, within the guidance of USD 118-128 million, down 10% year-on-year (YoY) and down 6% quarter-on-quarter (QoQ) - EBITDA was USD 15.9 million, up 35% YoY and down 9% QoQ - EBITDA margin of 13.4% was well above the 5-9% guidance - EBIT was USD -2.8 million, up USD 2.8 million YoY and down USD 1.3 million QoQ - Net loss was USD -5.9 million, up USD 2.2 million YoY and up USD 0.8 million QoQ - Bookings were USD...

Regulatory News: X-FAB Silicon Foundries SE (BOURSE:XFAB) 1. Summary of the notification X-FAB Silicon Foundries SE, listed on Euronext Paris, has received on August 6, 2020, a transparency notification. This transparency notification by Invesco Ltd., as the ultimate parent of Invesco Advisers, Inc. and Invesco Asset Management Limited, indicates that Invesco Advisers, Inc. and Invesco Asset Management Limited together hold 4.98% of the shares in X-FAB Silicon Foundries SE and have therefore...

Regulatory News: X-FAB Silicon Foundries SE (BOURSE:XFAB) 1. Summary of the notification X-FAB Silicon Foundries SE, listed on Euronext Paris, has received a transparency notification. This transparency notification by Invesco Ltd., as the ultimate parent of Invesco Advisers, Inc. and Invesco Asset Management Limited, indicates that Invesco Advisers, Inc. and Invesco Asset Management Limited together hold 5.04% of the shares in X-FAB Silicon Foundries SE, therefore exceeding the threshold of...